Latest news

Minutes from Annual General Meeting 2017

Posted on May 29, 2017

Oslo, 29 May 2017 – The Annual General Meeting in PCI Biotech Holding ASA took place today, 29 May 2017. All proposals in the call were approved. The Board of Directors were reelected and consists of the following members until the next Annual General Meeting:   * Hans Peter Bøhn, chairman   * Kjetil Taskén, […]

PCI Biotech presenting at Bio€quity Europe

Posted on May 23, 2017

Oslo, Norway, May 23, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, is presenting the Company at Bio€quity Europe, an investor and partnering event. Dr. Per Walday, CEO, will present an overview of PCI Biotech’s technology and the multiple business Development and commercial opportunities available based […]

PCI Biotech and RXi Pharmaceuticals Extend Research Collaboration to the Field of Immuno-oncology

Posted on May 22, 2017

Oslo (Norway), 22 May 2017 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, and RXi Pharmaceuticals (NASDAQ: RXII) a biotechnology company focused on developing novel RNAi therapeutics for significant un-met needs, today announced that they are extending their preclinical research collaboration initiated April 7, 2015.  This extension is supported by a new preclinical […]